AbbVie says deaths in arthritis trial not linked to drug

Print pagePDF pageEmail page

(Reuters) – AbbVie Inc said on Monday two patients died in a late-stage trial of its rheumatoid arthritis drug but that the deaths were not linked to the drug, which met the study’s main goals.


Reuters: Health News … More ادامه مطلب

Leave a Reply

Time limit is exhausted. Please reload CAPTCHA.